Additionally, serum levels of von Willebrand factor (vWF), tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1) are also monitored
Reported or possible side effects (anecdotal): Mild gastrointestinal discomfort Temporary increase in energy or alertness Mild fluctuations in appetite or hydration Potential interactions with other metabolic regulators Contraindications : Pregnant or breastfeeding individuals Patients with uncontrolled thyroid or adrenal disorders Individuals on insulin or glucose-lowering medications (unless medically supervised) Storage and Handling Store in a cool, dry place at 1525C (5977F) Keep container tightly closed Protect from light and moisture Keep out of reach of children For compounded or research use only , as directed by a licensed healthcare provider Why Choose 5-Amino-1MQ
What the evidence doesn't resolve is whether compounded GLP-1 preparations have equivalent efficacy and safety profiles to their brand-name FDA-approved counterparts
Karlsson FH, Tremaroli V, Nookaew I, Bergstrm G, Behre CJ, Fagerberg B, et al
Targeted Tissue Repair: ARA-290 binds exclusively to the Innate Repair Receptor (EPOR/CD131)